Nano-X Imaging Shares Are Rising Thursday: Here's Why
Nano-X Imaging Shares Are Rising Thursday: Here's Why
According to the company, the device has a smaller footprint and lower power requirements than conventional X-ray machines. It integrates with existing clinical workflows and aims to reduce patient wait times and streamline diagnostic processes.Nano-X Imaging Ltd. (NASDAQ:NNOX) shares are trading higher Thursday after the company announced FDA clearance for its Nano.ARC stationary x-ray system.
Nano-X Imaging Ltd.（納斯達克：NNOX）股價週四上漲，因該公司宣佈其Nano.ARC靜止X射線系統獲得FDA許可。
What To Know: Nano-X said it received 510(k) clearance from the FDA for its Nanox.ARC system, expanding the device's use to include pulmonary, intra-abdominal and paranasal imaging in addition to its previously cleared musculoskeletal indications.
了解一下：Nano-X表示，其Nanox.ARC系統獲得FDA頒發的510（k）許可，將該設備的使用範圍擴展到肺部、腹腔內和鼻旁成像，除了之前獲得的肌肉骨骼適應症。
The Nanox.ARC system uses advanced tomosynthesis technology and a cold cathode digital X-ray source to produce three-dimensional tomographic images. The technology reduces the overlap of anatomical structures common in traditional 2D X-rays, and is intended for professional use in hospitals, imaging centers and clinics.
Nanox.ARC系統採用先進的層析成像技術和冷陰極數字X射線源，產生三維層析圖像。該技術減少了傳統2D X射線中常見的解剖結構重疊，並旨在供專業人士在醫院、成像中心和診所使用。
According to the company, the device has a smaller footprint and lower power requirements than conventional X-ray machines. It integrates with existing clinical workflows and aims to reduce patient wait times and streamline diagnostic processes.
根據公司稱，該設備的佔地面積更小，功耗更低，比傳統X射線機器要求低。它與現有的臨床工作流程整合，並旨在減少患者等待時間，簡化診斷過程。
Erez Meltzer, CEO and acting chairman of Nano-X, stated that the clearance allows the company to offer broader imaging capabilities comparable to traditional X-ray devices. Meltzer emphasized the technology's role in improving diagnostic access and efficiency.
Nano-X的首席執行官兼代理主席Erez Meltzer表示，該許可允許公司提供與傳統X射線設備相媲美的更廣泛成像能力。 Meltzer強調了該技術在改善診斷訪問和效率方面的作用。
"Our mission is to provide healthcare practices with a transformative imaging advantage with the Nanox.ARC – an accessible, cost-effective solution that not only provides advanced diagnostic imaging capabilities but also elevates overall patient care," Meltzer said.
「我們的使命是爲醫療實踐提供具有變革性的成像優勢，即Nanox.ARC —— 一種可獲得、具有成本效益的解決方案，不僅提供先進的診斷成像功能，而且提升了整體患者護理質量，」 Meltzer說。
The Nanox.ARC is deployed in healthcare facilities across seven U.S. states and is undergoing deployment internationally for both clinical and commercial applications. The company anticipates that the expanded FDA-cleared indications will support further U.S. market growth.
Nanox.ARC已部署在美國七個州的醫療機構，並正在國際範圍內進行臨床和商業應用部署。公司預計擴大的FDA批准適應症將支持進一步的美國市場增長。
Greg Kicska, a member of the company's advisory board, noted that the system could add value in specific clinical settings, such as musculoskeletal, thoracic and abdominal imaging. He highlighted technical advantages, including reduced structural noise and a more compact design.
公司顧問委員會成員Greg Kicska指出，該系統在特定臨床環境中，如肌肉骨骼、胸部和腹部成像方面能夠增加價值。他強調了技術優勢，包括減少結構噪音和更緊湊的設計。
NNOX Price Action: Nano-X Imaging shares were up 3.66% at $6.48 at the time of writing, according to Benzinga Pro.
NNOX價格走勢：Nano-X Imaging股價在撰寫本文時上漲了3.66%，報6.48美元，據Benzinga Pro。
- Political Rivals, Real Estate Partners? JB Pritzker Buys Ken Griffin's $19M Gold Coast Condos
- 政敵，房地產合作伙伴？Jb Pritzker購買Ken Griffin的1900萬美元黃金海岸公寓
Image via Shutterstock.
圖片由shutterstock提供。
譯文內容由第三人軟體翻譯。
